<<  Back

Harvard Bioscience Elects James Green as Chairman of Board of Directors

Jun 07,2017

HOLLISTON, Mass., June 07, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has elected James Green, a current Board member, as the new Chairman of its Board of Directors effective June 5, 2017.  Earl R. Lewis has served as Chairman since July 2013 and has been a member of the Board since 2000.

James Green said, "It is an honor to be named Chairman of Harvard Bioscience and I look forward to this expanded role. As a member of the Board for the past two years, I have seen the executive team build a more effective operation while navigating a difficult market environment, and feel the team is poised to deliver shareholder value through expanding profitable growth."           

Jeffrey Duchemin, President and CEO, said, "James Green has been a valuable member of the Board since he joined two years ago.  He brings a tremendous amount of experience having been involved in global businesses that span the laboratory, instrumentation and technology sectors.  We are honored to have James Green lead our board as we continue to execute our strategy.  At the same time, we are extremely grateful that Earl Lewis, who has served as a Board member for 17 years, including Chairman for the past four years, will continue to contribute his knowledge, industry experience and insight to the Company."

Mr. Green was appointed a Director of the Company on April 30, 2015. He is the former President and Chief Executive Officer of Analogic Corporation, a leading publicly held advanced medical and security imaging company, a position that he held from 2007 to 2016. From 2005 to 2007, Mr. Green was Regional Vice President of the California division of Quest Diagnostics Corporation, successfully integrating the full Unilab sales and operations into the national laboratory network of Quest Diagnostics. From 1983 to 2005, he worked in various senior leadership positions at Koninklijke Philips Electronics NV, St. Jude Medical Inc., Beckman Instruments, McDonnell Douglas Corporation and Northrop Advanced Systems. Mr. Green holds a B.S. in Electrical Engineering from the University of Missouri at Columbia, an M.S. in Computer Engineering from the University of Southern California and is a graduate of the Stanford University Executive Program.

About Harvard Bioscience

Harvard Bioscience is a global developer, manufacturer and marketer of a broad range of solutions to advance life science. Our products are sold to thousands of researchers in over 100 countries through our global sales organization, websites, catalogs, and through distributors including Thermo Fisher Scientific Inc., VWR, and other specialized distributors. We have sales and manufacturing operations in the United States, the United Kingdom, Germany, Sweden, Spain, France, Canada and China. For more information, please visit our website at www.harvardbioscience.com.

For investor inquiries, please call (508) 893-8066. Press releases may be found on the Harvard Bioscience website.


Jeffrey A. Duchemin 
CEO and President

Robert E. Gagnon 

Corey Manchester 
Director, Finance and Investor Relations

Tel: 508 893 8999 
Fax: 508 429 8478 

DGI Comm
Public Relations: 
Susan Forman or Laura Radocaj